Progress and Promise
Vinflunine (20′,20′-difluoro- 3′,4′-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro
Pharmacokinetic and phase I studies of brequinar (DUP 785; NSC 368390) in combination with cisplatin in patients with advanced malignancies
Phase I study of paclitaxel (taxol) and granulocyte colony stimulating factor (G-CSF) in patients with unresectable malignancy
A phase I trial of vinorelbine in combination with mitoxantrone in patients with refractory solid tumors
Phase I study of DMP 840 in pediatric patients with refractory solid tumors
Phase I clinical study of didemnin B A National Cancer Institute of Canada Clinical Trials Group study
A phase I and pharmacokinetic trial of terephthalamidine (NSC 57155) as a 120-hour continuous infusion
Phase I trial of edatrexate plus carboplatin in advanced solid tumors : amelioration of dose-limiting mucositis by ice chip cryotherapy
A phase II study of Temozolomide in advanced untreated pancreatic cancer
Phase II study of intravenous adenosine 5′-triphosphate in patients with previously untreated stage IIIB and Stage IV non-small cell lung cancer
Phase II study of CI-980 (NSC 635370) in patients with previously treated advanced soft-tissue sarcomas
Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinoma